在新辅助系统治疗后,瘤塑性乳房保护手术的瘤和化品结局:系统性审查和元分析
Goran A Ahmed1, Daniel H Baron2,3, Amit Agrawal4,5
1Frimley Park Hospital, Frimley Health NHS Foundation Trust, Camberley, UK.
Breast cancer research and treatment
|December 14, 2024
概括
瘤塑性乳房保护手术 (OBCS) 提供与标准乳房保护手术 (SBCS) 和乳房切除术相比较的瘤安全性. OBCS表现出改善的化品结果和较低的再切割率,使其成为新辅助疗法后的可行选择.
科学领域:
- 手术瘤学手术瘤学
- 乳腺癌治疗方法 乳腺癌治疗方法
- 整形和重建手术 整形和重建手术
背景情况:
- 瘤塑性乳腺保护手术 (OBCS) 旨在改善乳腺癌中大切割后的美学结果.
- 对标准乳房保护手术 (SBCS) 和乳房切除术进行OBCS评估至关重要,特别是在新辅助全身治疗后.
研究的目的:
- 系统地审查和比较OBCS与SBCS和乳房切除的瘤,手术和化品结果.
- 评估OBCS在接受乳腺癌新辅助全身治疗的患者的疗效.
主要方法:
- 在2024年8月之前发表的RCT和观察性研究的系统审查.
- 在选6794篇文章后,包括了11项涉及4594名患者的队列研究.
- 数据提取和偏差风险评估由两个独立的审稿人进行,并在可行的情况下进行元分析.
主要成果:
- 与SBCS相比,OBCS的保证金再裁减率明显较低 (2.9%对6.1%).
- 在其他瘤结局方面没有发现显著差异,包括OBCS,SBCS和乳腺切除组的阳性边际率和整体存活率.
- 整容结果和患者报告的满意度偏好OBCS (50-66%非常满意) 与SBCS (37.6-55%非常满意).
结论:
- 在新辅助全身疗法 (NACT) 后,OBCS在瘤学上是安全的,并且为部分或较差瘤反应的患者提供了良好的替代方案.
- 需要进一步的研究,直接比较与SBCS和乳腺切除术后NACT组匹配的OBCS.
关键词:
(细分) 乳房切除术 (细分) 乳房切除术乳腺癌 乳腺癌 乳腺癌胸部墙壁穿孔器的片乳房整形手术 (Mammoplasty) 是一个整形手术.新辅助化学疗法新辅助化学疗法瘤塑性乳房保护性手术标准的乳房保护手术是标准的.更多相关视频
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.5K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K